Log on / register
Feedback | Support | My details
Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants.
Kleer CG, van Golen KL, Merajver SD
Breast Cancer Res 2000, 2:423-9
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.
Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY
Br J Cancer 2007 Sep 3, 97:659-69
 [PubMed Central] [PubMed] [Related articles]
2.
Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis.
Van Laere S, Van der Auwera I, Van den Eynden G, Van Hummelen P, van Dam P, Van Marck E, Vermeulen PB, Dirix L
Br J Cancer 2007 Oct 22, 97:1165-74
 [PubMed Central] [PubMed] [Related articles]
3.
Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase.
Han YP, Nien YD, Garner WL
J Biol Chem 2002 Jul 26, 277:27319-27
 [PubMed Central] [PubMed] [Related articles]
4.
Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment.
de M Souza CH, Toledo-Piza E, Amorin R, Barboza A, Tobias KM
Can Vet J 2009 May, 50:506-10
 [PubMed Central] [PubMed] [Related articles]
5.
Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness.
Blot E, Chen W, Vasse M, Paysant J, Denoyelle C, Pillé JY, Vincent L, Vannier JP, Soria J, Soria C
Br J Cancer 2003 Apr 22, 88:1207-12
 [PubMed Central] [PubMed] [Related articles]
6.
The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers.
Lemieux J, Clemons M, Provencher L, Dent S, Latreille J, Mackey J, Pritchard KI, Rayson D, Verma S, Verma S, Wang B, Chia S
Curr Oncol 2009 Sep, 16:48-57
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 5 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.